StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | PCRX Pacira BioSciences | $23.04 | +0.88% | — | — | — | — | — | 32 |
| 1 | LLY Eli Lilly | $1015.75 | +2.57% | — | — | — | — | — | 75 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $133.05 |
| -2.14% |
| — |
| — |
| — |
| — |
| — |
| 52 |
| 3 | REGN Regeneron | $719.88 | -0.56% | — | — | — | — | — | 51 |
| 4 | BNTX BioNTech | $92.23 | -1.53% | — | — | — | — | — | 49 |
| 5 | MRNA Moderna | $50.42 | -5.44% | — | — | — | — | — | 48 |
| 6 | TEM Tempus AI | $45.90 | -1.75% | — | — | — | — | — | 48 |
| 7 | VRTX Vertex Pharma | $453.06 | +0.63% | — | — | — | — | — | 46 |
| 8 | NVO Novo Nordisk | $47.08 | +0.38% | — | — | — | — | — | 44 |
| 9 | AMGN Amgen | $336.45 | +0.05% | — | — | — | — | — | 39 |